Robert Gagnon
Director/Board Member chez PURPLE BIOTECH LTD
Fortune : 323 214 $ au 31/03/2024
Profil
Robert E.
Gagnon is currently serving as the Secretary, Treasurer & Director at KD Scientific, Inc. He is also a Director at Verastem, Inc., an Independent Director at Purple Biotech Ltd., and a Director at Bone Biologics Corp.
Additionally, he holds positions as a Director at Verastem Oncology and as the Chief Financial Officer at Remix Therapeutics, Inc. In his former roles, Gagnon served as the Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc. from 2012 to 2013.
He was also the CAO, VP-Business Planning & Controller at Biogen, Inc. from 2005 to 2012.
From 2013 to 2018, he served as the Chief Financial Officer at Harvard Bioscience, Inc. Gagnon then became the Chief Financial & Business Officer at Verastem, Inc. from 2018 to 2022.
He also worked as the Manager-Research & Development at Zimmer Biomet, Inc. from 2013 to 2017.
Gagnon completed his undergraduate studies at Bentley University and holds an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERASTEM, INC.
0,11% | 19/03/2024 | 27 391 ( 0,11% ) | 323 214 $ | 31/03/2024 |
BONE BIOLOGICS CORP.
-.--% | 08/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Robert Gagnon
| Sociétés | Poste | Début |
|---|---|---|
| PURPLE BIOTECH LTD | Director/Board Member | 03/03/2021 |
| VERASTEM, INC. | Director/Board Member | 13/12/2022 |
| BONE BIOLOGICS CORPORATION | Director/Board Member | 08/01/2024 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Director/Board Member | - |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Anciens postes connus de Robert Gagnon
| Sociétés | Poste | Fin |
|---|---|---|
| VERASTEM, INC. | Director of Finance/CFO | 31/10/2022 |
| HARVARD BIOSCIENCE, INC. | Director of Finance/CFO | 31/08/2018 |
| Zimmer Biomet, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| CLEAN HARBORS, INC. | Director of Finance/CFO | 04/02/2013 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Gagnon
| Bentley University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| CLEAN HARBORS, INC. | Industrial Services |
| BIOGEN INC. | Health Technology |
| HARVARD BIOSCIENCE, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| PURPLE BIOTECH LTD | Health Technology |
| BONE BIOLOGICS CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Health Technology |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
| Zimmer Biomet, Inc. |
